Xtant Medical Holdings Inc. logo

Xtant Medical Holdings Inc. (XMS)

Market Open
8 Dec, 06:35
XSTU XSTU
0. 50
+0.01
+2.04%
- Market Cap
90.45 P/E Ratio
0% Div Yield
0 Volume
-0.06 Eps
0.49
Previous Close
Day Range
0.5 0.51
Year Range
0.32 0.77
Want to track XMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 87 days

Summary

XMS trading today higher at €0.5, an increase of 2.04% from yesterday's close, completing a monthly increase of 3.73% or €0.02. Over the past 12 months, XMS stock gained 24.38%.
XMS is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports. The next scheduled earnings report is due on Mar 05, 2026.
Xtant Medical Holdings Inc. has completed 1 stock splits, with the recent split occurring on Feb 14, 2018.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on AMEX (USD).

XMS Chart

Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. ( XTNT ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Sean Browne - President, CEO & Director Scott Neils - Chief Financial Officer Conference Call Participants Kevin Gardner Ryan Zimmerman - BTIG, LLC, Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good morning, everyone, and welcome to the Xtant Medical Third Quarter 2025 Financial Results. [Operator Instructions].

Seekingalpha | 3 weeks ago
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Scott C. Neils - Chief Financial Officer Sean E.

Seekingalpha | 3 months ago
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President and Chief Executive Officer Scott Neils - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Ryan Zimmerman - BTIG Operator Good afternoon, everyone, and welcome to the Xtant Medical's First Quarter 2025 Financial Results. At this time, all participants are in a listen-only mode, and the floor will be open for questions following the presentation.

Seekingalpha | 6 months ago

Xtant Medical Holdings Inc. (XMS) FAQ

What is the stock price today?

The current price is €0.50.

On which exchange is it traded?

Xtant Medical Holdings Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is XMS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Mar 05, 2026.

Has Xtant Medical Holdings Inc. ever had a stock split?

Xtant Medical Holdings Inc. had 1 splits and the recent split was on Feb 14, 2018.

Xtant Medical Holdings Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Sean E. Browne CEO
XSTU Exchange
US98420P3082 ISIN
US Country
217 Employees
- Last Dividend
14 Feb 2018 Last Split
19 Oct 2015 IPO Date

Overview

Xtant Medical Holdings, Inc. focuses on developing, manufacturing, and marketing a range of regenerative medicine products and medical devices tailored for the needs of orthopedic and neurological surgeons both in the U.S. and internationally. Originating as Bacterin International Holdings, Inc., the company transitioned to its current name in July 2015, embodying a broader scope in regenerative medicine and medical device innovation. Operating from its headquarters in Belgrade, Montana, Xtant Medical Holdings, Inc. leverages cutting-edge science to foster advancements in medical treatments and patient care across various specialties including orthopedics, neurology, and more.

Products and Services

  • OsteoSponge: Offers a natural scaffold facilitating cellular in-growth and exposes bone-forming proteins to optimize healing.
  • OsteoSponge SC: This product is designed to fill bony defects in the subchondral region of joints, aiding in the process of bone regeneration and repair.
  • OsteoSelect DBM Putty: An osteoinductive bone growth material, OsteoSelect DBM Putty supports the restoration of bone defects and voids as a bone graft substitute in various surgical applications.
  • OsteoSelect PLUS DBM Putty: An enhanced version of the DBM Putty, OsteoSelect PLUS is utilized as a bone void filler and bone graft substitute, specifically in the pelvis, extremities, and posterolateral spine.
  • OsteoFactor: Contains a myriad of proteins and peptides supportive of bone formation and remodeling, facilitating effective bone regeneration.
  • OsteoWrap: A regenerative medicine product designed to support bone repair and growth, enhancing the healing ecosystem.
  • OsteoVive Plus: A growth factor enriched cellular bone matrix, intended for effective bone repair and growth stimulation.
  • 3Demin: Represents a family of allografts that maximize the osteoconductivity and osteoinductive potential of human bone, implying high adaptability and functionality in bone regeneration.
  • Sports Allografts: Processed and distributed for crucial ligament repairs, including those required for anterior and posterior cruciate ligament, and meniscal repair.
  • Milled Spinal Allografts: Specialized allografts milled to precise dimensions for cortical bone applications, typically utilized in spinal surgeries.
  • Traditional Allografts: Provided for a range of applications across orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive operations.
  • Certex Spinal Fixation, Spider Cervical Plating, Axle Interspinous Fusion, Silex Sacroiliac Joint Fusion, Xpress Minimally Invasive Pedicle Screw, and Fortex Pedicle Screw Systems: A suite of advanced medical devices offering comprehensive solutions for spinal surgeries, from fixation to fusion technologies.
  • Calix for cervical and thoracolumbar applications, Axle-X Interspinous Fusion System, Irix-C Cervical Integrated Fusion System, and Irix-A Lumbar Integrated Fusion System: These systems provide integrated solutions for spinal fusion surgeries, featuring technologically advanced designs to improve patient outcomes.

Contact Information

Address: 664 Cruiser Lane
Phone: 406 388 0480